What a year! The future looking bright....
Likely Developments and Overview of Group Strategy
The Company’s upcoming catalysts and strategy are focussed on the following areas:
• Continued acceleration of sales and ARR growth within RAC sector in ANZ, UK, Canada and new
EU opportunities
• Complete FDA studies to lodge for US FDA De Novo clearance in Q4 2023
• Leverage existing US partnerships including Point Click Care, InterSystems and Ethos Labs to
prepare for US market entry in 2024
• Build on existing Home Care and Disability markets
• Enter global hospital market sector with InterSystems partnership
• Commence “direct to parent” sales and marketing for Infant App
The Company will also be completing a technology upgrade in 2023 and applying for ISO 27001
certification following implementation of Information Management Systems and processes.
Happy Friday Punters..
What a year! The future looking bright....Likely Developments...
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $47.43M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.8¢ | $29.41K | 1.040M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87500 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 185660 | 1 |
View Market Depth
| Last trade - 15.47pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
0.001 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.9¢ | 2.7¢ | 94371 | ||
| Last updated 15.41pm 03/05/2024 ? | |||||
| PCK (ASX) Chart |